Global On-body Injectors Market Research Report 2025

Publication ID:

PB503253963

Publication Date:

March 7, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for On-body Injectors was valued at US$ 176 million in the year 2024 and is projected to reach a revised size of US$ 462 million by 2031, growing at a CAGR of 15.0% during the forecast period.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 On-body Injectors Market Overview
1.1 Product Definition
1.2 On-body Injectors by Type
1.2.1 Global On-body Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors by Application
1.3.1 Global On-body Injectors Market Value by Application (2024 VS 2031)
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2020-2031
1.4.2 Global On-body Injectors Sales 2020-2031
1.4.3 Global On-body Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global On-body Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
2.7 Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
2.8 Global On-body Injectors Market Competitive Situation and Trends
2.8.1 Global On-body Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
2.8.3 Global On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-body Injectors Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global On-body Injectors Sales by Region: 2020-2031
3.2.1 Global On-body Injectors Sales by Region: 2020-2025
3.2.2 Global On-body Injectors Sales by Region: 2026-2031
3.3 Global On-body Injectors Revenue by Region: 2020-2031
3.3.1 Global On-body Injectors Revenue by Region: 2020-2025
3.3.2 Global On-body Injectors Revenue by Region: 2026-2031
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America On-body Injectors Sales by Country (2020-2031)
3.4.3 North America On-body Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe On-body Injectors Sales by Country (2020-2031)
3.5.3 Europe On-body Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific On-body Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific On-body Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific On-body Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America On-body Injectors Sales by Country (2020-2031)
3.7.3 Latin America On-body Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2020-2031)
4.1.1 Global On-body Injectors Sales by Type (2020-2025)
4.1.2 Global On-body Injectors Sales by Type (2026-2031)
4.1.3 Global On-body Injectors Sales Market Share by Type (2020-2031)
4.2 Global On-body Injectors Revenue by Type (2020-2031)
4.2.1 Global On-body Injectors Revenue by Type (2020-2025)
4.2.2 Global On-body Injectors Revenue by Type (2026-2031)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2020-2031)
4.3 Global On-body Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2020-2031)
5.1.1 Global On-body Injectors Sales by Application (2020-2025)
5.1.2 Global On-body Injectors Sales by Application (2026-2031)
5.1.3 Global On-body Injectors Sales Market Share by Application (2020-2031)
5.2 Global On-body Injectors Revenue by Application (2020-2031)
5.2.1 Global On-body Injectors Revenue by Application (2020-2025)
5.2.2 Global On-body Injectors Revenue by Application (2026-2031)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2020-2031)
5.3 Global On-body Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Company Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Company Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Company Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Company Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Company Information
6.11.2 Sonceboz Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Company Information
6.12.2 Lohmann Therapie-Systeme Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Company Information
6.13.2 Elcam Drug Delivery Devices (E3D) Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process Analysis
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customer Analysis
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂